Thank You for Making the SSO 2020 Virtual Meeting a Success!
Thanks for participating in theSSO 2020 Virtual Meeting. The two nights of programming saw phenomenal attendance and featured provocative and inspiring lectures. If you missed a session or would like to replay a presentation, visitExpertEd@SSO.
Explore the All New ExpertEd@SSO
Your source for premier surgical oncology education is now better than ever! ExpertEd@SSO has been completely overhauled and utilizes a new technology platform to deliver programs developed and facilitated by world leaders in surgical oncology. This new platform offers:
- Mobile responsive design
- One-click access to a searchable program catalog (no login required)
- Microlearning educational formats.
Listen to the Latest Episode of the SurgOnc Today Podcast
“Updates in the Management of Colorectal Cancer and Peritoneal Disease”
In this episode ofSurgOnc Today, Sean Dineen, MD, Laura Lambert, MD, and Chukwuemeka Ihemelandu, MD, discuss the state of the art management of colorectal cancer metastatic to the peritoneum including natural history and treatment options. They also preview future directions for the field.
Virtual Tumor Board: Melanoma Disease and COVID-19
This virtual tumor board discussion will include phases of COVID-19 pandemic, regional variances/differences including direct impact of COVID-19 case numbers and impact on hospital/hospital system workflows and treatment guidelines during COVID-19.
Virtual Tumor Board: Gastrointestinal Disease and COVID-19
This virtual tumor board discussion will include COVID-19 in New York City Hospitals: resources, staffing and precautions, chemotherapy in high-risk situations, evaluating patients prior to initiation of treatment, and triage and restarting of elective procedures.
The virtual tumor board discussion will include options for temporizing surgical intervention in the face of limitations on PPE and strategies to mitigate risk for patients whose surgery cannot be postponed, options for temporizing and adjusting medical management in the face of necessary surgical delays, including risks for administering systemic chemotherapy and radiation oncology strategies in the face of a pandemic.
Virtual Tumor Board: Colorectal Disease and Covid-19
This virtual tumor board discussion will include management of CRC during COVID-19, analysis and interpretation of data regarding TNT and short-course radiation and timing of surgery for rectal cancer, understanding therapeutic choices and pre-treatment testing and precautions with the use of minimally invasive approaches and potential risks and complications when operating on COVID-19 patients with CRC.
This virtual tumor board discussion will include discussion about the current state and recovery from COVID-19 and discussion of ethics and surgical triage in the time of COVID-19.
Virtual Tumor Board: Sarcoma Disease and COVID-19
The virtual tumor board discussion will include the current state and recovery from COVID-19 in New York City and Tampa, current practices in the management of STS and pre-treatment testing and precautions.
Virtual Tumor Board: Hepato-Pancreato-Biliary Disease and COVID-19
The virtual tumor board discussion will include COVID-19 status at various facilities, considerations for cases coming off therapy versus newly diagnosed and the role of neoadjuvant, chemotherapy and radiation therapy.
This virtual tumor board discussion will include approaches to pre-operative testing, understanding the landscape of management of PSM during COVID-19 in the US, how long it is safe to keep patients on chemotherapy who are CRS/HIPEC candidates and analyzing and interpreting risks of chemotherapy during COVID-19.
Earn CME credit by reading select articles from SSO’sAnnals of Surgical Oncology. Articles are available on a variety of topics and are complementary to SSO members. Check out the newest articles – Neoadjuvant Versus Adjuvant Immune Checkpoint Blockade in the Treatment of Clinical Stage III Melanoma and The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of CMEsolutions and North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.The CMEsolutions designates this enduring activity for a maximum of 2 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Reminder: You must attend both webinars to obtain accreditation.
